University of California San Francisco
Give to UCSF
Specific DNA once dismissed as junk plays an important role in brain development and might be involved in several devastating neurological diseases, UCSF scientists have found.
A Phase 2 clinical trial testing a new protocol for treating a relatively rare form of brain cancer, primary CNS lymphoma, may change the standard of care for this disease, according to UCSF doctors who led the research.
UCSF neurologist Stephen Hauser has been named the winner of its 2013 Charcot award, the top international prize for lifetime achievement in multiple sclerosis research.
By stimulating one part of the brain with laser light, researchers at the National Institutes of Health and the Ernest Gallo Clinic and Research Center at UCSF have shown that they can wipe away addictive behavior in rats – or conversely turn non-addicted rats into compulsive cocaine seekers.
UCSF has recently partnered with Lawrence Berkeley National Laboratory and UC Berkeley to form the Tri-Institutional Partnership, in an effort to promote collaborative research among the three institutions.
Electroencephalogram, which measures and records electrical activity in the brain, is a quick and efficient way of determining whether seizures are the cause of altered mental status and spells, according to a UCSF study.
<p>A team of researchers at UCSF has uncovered the neurological basis of speech motor control, the complex coordinated activity of tiny brain regions that controls our lips, jaw, tongue and larynx as we speak.</p>
Hospital MRIs may be better at predicting long-term outcomes for people with mild traumatic brain injuries than CT scans, according to a clinical trial led by researchers at UCSF and the San Francisco General Hospital and Trauma Center.
William Seeley maps the path of frontotemporal dementia through the brain, correlating specific damage with behavioral change. By studying the disease from self to circuits to cells, this visionary neurologist searches for inroads to treatment.
DNA sequences obtained from a handful of patients with multiple sclerosis at the UCSF Medical Center have revealed the existence of an “immune exchange” that allows the disease-causing cells to move in and out of the brain.
<p>UCSF neuroscientists have found that by training on attention tests, people young and old can improve brain performance and multitasking skills.</p>
<p>As part of receiving the Academic Senate's 12th Annual Faculty Research Lectureship in Clinical Science, behavioral neurologist Bruce Miller, MD, recently gave a lecture in which he described recent advances in frontotemporal dementia (FTD) research.</p>
<p>A new study that represents a significant first step in exploring the potential of stem cells to treat neurological disease is a “natural outgrowth” of a longstanding culture of interdisciplinary collaboration in UCSF neonatology — a culture that UCSF Benioff Children's Hospital physicians David Rowitch and Donna Ferriero work hard to sustain.</p>
<p>Biomedical researchers at UCSF have won five of 51 prestigious National Institutes of Health Director’s New Innovator awards for high-risk, high-reward research, each receiving up to $1.5 million over five years.</p>
<p><span>Research has shown that women are at greater risk of post-traumatic stress disorder (PTSD) than men. Now, scientists based at the UCSF-affiliated San Francisco Veterans Affairs Medical Center (SFVAMC) have found that women with the condition might be more likely to experience faster aging at the cellular level and increased risk for diseases of aging than men with PTSD.</span></p>
<p>There is no cure for multiple sclerosis, but several medications can help slow its devastating effects, and extend healthier years for the roughly 2.5 million people worldwide diagnosed with this chronic neurological disease.</p>
Scientists at the UCSF-affiliated Gladstone Institutes have discovered that an FDA-approved anti-epileptic drug reverses memory loss and alleviates other Alzheimer’s-related impairments in an animal model of the disease.
As mothers have always known, a good night’s sleep is crucial to good health — and now a new study led by a Robert Wood Johnson Foundation Health & Society Scholar at UCSF and UC Berkeley shows that poor sleep can reduce the effectiveness of vaccines.
Raising levels of the neurotransmitter dopamine in the frontal cortex of the brain significantly decreased impulsivity in healthy adults, in a study conducted by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco.
Scientists at the UCSF-affiliated Gladstone Institutes participated in the national Human Microbiome Project, which used groundbreaking methods to vastly improve the understanding of bacteria that reside in and on the human body.